Geeta Laboratories Profile
Key Indicators
- Authorised Capital ₹ 0.20 M
- Paid Up Capital ₹ 0.11 M
- Company Age 22 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 13.89 Cr
- Revenue Growth 51.78%
- Profit Growth 33.05%
- Ebitda 49.16%
- Net Worth 32.53%
- Total Assets 57.51%
About Geeta Laboratories
Geeta Laboratories Private Limited (GLPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 10 May 2002 and has a history of 22 years and nine months. Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.20 M and a paid-up capital of Rs 0.11 M.
The company currently has active open charges totaling ₹13.89 Cr.
Deepal Shah and Surekha Shah serve as directors at the Company.
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24230MH2002PTC135843
- Company No.
135843
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
10 May 2002
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Pharma
Who are the key members and board of directors at Geeta Laboratories?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Deepal Shah  | Director | 10-May-2002 | Current |
| Surekha Shah | Director | 10-May-2002 | Current |
Financial Performance of Geeta Laboratories.
Geeta Laboratories Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 51.78% increase. The company also saw a substantial improvement in profitability, with a 33.05% increase in profit. The company's net worth Soared by an impressive increase of 32.53%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Geeta Laboratories?
In 2022, Geeta Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Enovative Ideas Private LimitedDeepal Shah is a mutual person
Charges (Loans)
Open Charges
₹138.94 M
Satisfied Charges
₹0
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 13.89 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 29 Nov 2019 | Hdfc Bank Limited | ₹11.89 Cr | Open |
| 06 Sep 2014 | Hdfc Bank Limited | ₹2.00 Cr | Open |
How Many Employees Work at Geeta Laboratories?
Unlock and access historical data on people associated with Geeta Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Geeta Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Geeta Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
